

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.21636216 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.21636216 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 5.90650301 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.90650301 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.42930529 |
| 6 | melanin biosynthetic process (GO:0042438) | 5.38032753 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.37608659 |
| 8 | melanin metabolic process (GO:0006582) | 5.06957563 |
| 9 | alpha-linolenic acid metabolic process (GO:0036109) | 5.01944094 |
| 10 | bile acid biosynthetic process (GO:0006699) | 4.90609757 |
| 11 | kynurenine metabolic process (GO:0070189) | 4.79149042 |
| 12 | tryptophan catabolic process (GO:0006569) | 4.75022940 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 4.75022940 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 4.75022940 |
| 15 | negative regulation of fibrinolysis (GO:0051918) | 4.73743688 |
| 16 | urea metabolic process (GO:0019627) | 4.71084542 |
| 17 | urea cycle (GO:0000050) | 4.71084542 |
| 18 | glyoxylate metabolic process (GO:0046487) | 4.70071561 |
| 19 | protein carboxylation (GO:0018214) | 4.64394972 |
| 20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.64394972 |
| 21 | cysteine metabolic process (GO:0006534) | 4.57159469 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 4.56481562 |
| 23 | regulation of fibrinolysis (GO:0051917) | 4.55484545 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 4.55116698 |
| 25 | regulation of protein activation cascade (GO:2000257) | 4.48918044 |
| 26 | tryptophan metabolic process (GO:0006568) | 4.47267561 |
| 27 | nuclear pore complex assembly (GO:0051292) | 4.42280833 |
| 28 | desmosome organization (GO:0002934) | 4.42238763 |
| 29 | homocysteine metabolic process (GO:0050667) | 4.39063307 |
| 30 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.29835231 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 4.27743759 |
| 32 | bile acid metabolic process (GO:0008206) | 4.27322804 |
| 33 | regulation of complement activation (GO:0030449) | 4.24827384 |
| 34 | serine family amino acid catabolic process (GO:0009071) | 4.20820732 |
| 35 | complement activation, alternative pathway (GO:0006957) | 4.20553952 |
| 36 | regulation of triglyceride catabolic process (GO:0010896) | 4.19667216 |
| 37 | reverse cholesterol transport (GO:0043691) | 4.19631713 |
| 38 | regulation of cholesterol homeostasis (GO:2000188) | 4.14266944 |
| 39 | amino-acid betaine metabolic process (GO:0006577) | 4.14110858 |
| 40 | regulation of bile acid biosynthetic process (GO:0070857) | 4.10594194 |
| 41 | secondary metabolite biosynthetic process (GO:0044550) | 4.06949782 |
| 42 | lysine metabolic process (GO:0006553) | 4.05834691 |
| 43 | lysine catabolic process (GO:0006554) | 4.05834691 |
| 44 | triglyceride homeostasis (GO:0070328) | 4.04929866 |
| 45 | acylglycerol homeostasis (GO:0055090) | 4.04929866 |
| 46 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.99423350 |
| 47 | plasma lipoprotein particle remodeling (GO:0034369) | 3.95767012 |
| 48 | protein-lipid complex remodeling (GO:0034368) | 3.95767012 |
| 49 | macromolecular complex remodeling (GO:0034367) | 3.95767012 |
| 50 | cellular glucuronidation (GO:0052695) | 3.93740537 |
| 51 | plasma lipoprotein particle clearance (GO:0034381) | 3.93345711 |
| 52 | aromatic amino acid family metabolic process (GO:0009072) | 3.91273175 |
| 53 | tyrosine metabolic process (GO:0006570) | 3.89202117 |
| 54 | regulation of cholesterol esterification (GO:0010872) | 3.87710475 |
| 55 | cellular ketone body metabolic process (GO:0046950) | 3.83517548 |
| 56 | intestinal cholesterol absorption (GO:0030299) | 3.81243393 |
| 57 | bile acid and bile salt transport (GO:0015721) | 3.80455521 |
| 58 | alpha-amino acid catabolic process (GO:1901606) | 3.79738631 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 3.79708902 |
| 60 | negative regulation of sterol transport (GO:0032372) | 3.79708902 |
| 61 | phospholipid efflux (GO:0033700) | 3.79391228 |
| 62 | coenzyme catabolic process (GO:0009109) | 3.72912989 |
| 63 | nuclear pore organization (GO:0006999) | 3.72118119 |
| 64 | cellular modified amino acid catabolic process (GO:0042219) | 3.68458860 |
| 65 | cholesterol efflux (GO:0033344) | 3.60420561 |
| 66 | glutamate metabolic process (GO:0006536) | 3.59755346 |
| 67 | fibrinolysis (GO:0042730) | 3.59341773 |
| 68 | phospholipid homeostasis (GO:0055091) | 3.58439706 |
| 69 | pore complex assembly (GO:0046931) | 3.57589638 |
| 70 | positive regulation of lipid catabolic process (GO:0050996) | 3.57131773 |
| 71 | cellular amino acid catabolic process (GO:0009063) | 3.57059222 |
| 72 | acetyl-CoA metabolic process (GO:0006084) | 3.53988213 |
| 73 | short-chain fatty acid metabolic process (GO:0046459) | 3.51108777 |
| 74 | serine family amino acid metabolic process (GO:0009069) | 3.49523876 |
| 75 | glycine metabolic process (GO:0006544) | 3.49234916 |
| 76 | cholesterol homeostasis (GO:0042632) | 3.47857695 |
| 77 | plasma lipoprotein particle assembly (GO:0034377) | 3.47008966 |
| 78 | serine family amino acid biosynthetic process (GO:0009070) | 3.44477387 |
| 79 | drug catabolic process (GO:0042737) | 3.43745061 |
| 80 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.43660884 |
| 81 | sterol homeostasis (GO:0055092) | 3.43041517 |
| 82 | ethanol oxidation (GO:0006069) | 3.39929360 |
| 83 | uronic acid metabolic process (GO:0006063) | 3.39679947 |
| 84 | glucuronate metabolic process (GO:0019585) | 3.39679947 |
| 85 | fatty acid beta-oxidation (GO:0006635) | 3.37159705 |
| 86 | positive regulation of fatty acid oxidation (GO:0046321) | 3.36556254 |
| 87 | epoxygenase P450 pathway (GO:0019373) | 3.35684245 |
| 88 | hemidesmosome assembly (GO:0031581) | 3.35304647 |
| 89 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.34992690 |
| 90 | heme transport (GO:0015886) | 3.34593301 |
| 91 | ketone body metabolic process (GO:1902224) | 3.34283311 |
| 92 | lipoprotein metabolic process (GO:0042157) | 3.34174039 |
| 93 | negative regulation of protein activation cascade (GO:2000258) | 3.33144843 |
| 94 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.31962673 |
| 95 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.31962673 |
| 96 | aspartate family amino acid catabolic process (GO:0009068) | 3.30892574 |
| 97 | protein-lipid complex assembly (GO:0065005) | 3.28500382 |
| 98 | fatty acid oxidation (GO:0019395) | 3.27922407 |
| 99 | indolalkylamine metabolic process (GO:0006586) | 3.26394175 |
| 100 | regulation of cholesterol metabolic process (GO:0090181) | 3.26285304 |
| 101 | carboxylic acid catabolic process (GO:0046395) | 3.23449438 |
| 102 | organic acid catabolic process (GO:0016054) | 3.23449438 |
| 103 | lipid oxidation (GO:0034440) | 3.23351585 |
| 104 | regulation of plasminogen activation (GO:0010755) | 3.22520894 |
| 105 | arginine metabolic process (GO:0006525) | 3.22024281 |
| 106 | fatty acid catabolic process (GO:0009062) | 3.21783020 |
| 107 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.21609783 |
| 108 | monocarboxylic acid catabolic process (GO:0072329) | 3.19776693 |
| 109 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.18268720 |
| 110 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.17433806 |
| 111 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.13120335 |
| 112 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.10069564 |
| 113 | chromosome condensation (GO:0030261) | 3.07598823 |
| 114 | negative regulation of fatty acid transport (GO:2000192) | 3.06075019 |
| 115 | basement membrane organization (GO:0071711) | 3.00936266 |
| 116 | actin filament depolymerization (GO:0030042) | 2.95087961 |
| 117 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.90104936 |
| 118 | COPII vesicle coating (GO:0048208) | 2.84842795 |
| 119 | DNA packaging (GO:0006323) | 2.83272047 |
| 120 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.81908284 |
| 121 | regulation of RNA export from nucleus (GO:0046831) | 2.81510106 |
| 122 | histone H3-K36 demethylation (GO:0070544) | 2.76868254 |
| 123 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.75911756 |
| 124 | melanocyte differentiation (GO:0030318) | 2.67283443 |
| 125 | cell-substrate junction assembly (GO:0007044) | 2.65937829 |
| 126 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.64641311 |
| 127 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.60542010 |
| 128 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.58112080 |
| 129 | pigment cell differentiation (GO:0050931) | 2.58005066 |
| 130 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.57464859 |
| 131 | G1 DNA damage checkpoint (GO:0044783) | 2.57278211 |
| 132 | regulation of water loss via skin (GO:0033561) | 2.56800997 |
| 133 | sexual reproduction (GO:0019953) | 2.56765593 |
| 134 | skin morphogenesis (GO:0043589) | 2.53837909 |
| 135 | dermatan sulfate biosynthetic process (GO:0030208) | 2.52803710 |
| 136 | * semaphorin-plexin signaling pathway (GO:0071526) | 2.51758526 |
| 137 | endocardial cushion development (GO:0003197) | 2.51490003 |
| 138 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.49848759 |
| 139 | COPI coating of Golgi vesicle (GO:0048205) | 2.49474842 |
| 140 | Golgi transport vesicle coating (GO:0048200) | 2.49474842 |
| 141 | intestinal epithelial cell development (GO:0060576) | 2.49254216 |
| 142 | cell adhesion mediated by integrin (GO:0033627) | 2.47925267 |
| 143 | embryonic foregut morphogenesis (GO:0048617) | 2.46344798 |
| 144 | mitotic G1/S transition checkpoint (GO:0044819) | 2.44803944 |
| 145 | peptidyl-lysine dimethylation (GO:0018027) | 2.44378805 |
| 146 | histone H3-K9 demethylation (GO:0033169) | 2.44225029 |
| 147 | mitotic sister chromatid cohesion (GO:0007064) | 2.42461850 |
| 148 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.41970253 |
| 149 | dermatan sulfate metabolic process (GO:0030205) | 2.40893778 |
| 150 | endosome to melanosome transport (GO:0035646) | 2.40300099 |
| 151 | endosome to pigment granule transport (GO:0043485) | 2.40300099 |
| 152 | intestinal absorption (GO:0050892) | 2.40172405 |
| 153 | smooth muscle tissue development (GO:0048745) | 2.35980112 |
| 154 | vitamin transmembrane transport (GO:0035461) | 2.34190367 |
| 155 | hair cell differentiation (GO:0035315) | 2.31751851 |
| 156 | lipid translocation (GO:0034204) | 2.29971414 |
| 157 | phospholipid translocation (GO:0045332) | 2.29971414 |
| 158 | embryonic eye morphogenesis (GO:0048048) | 2.28651063 |
| 159 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.28024091 |
| 160 | chondrocyte proliferation (GO:0035988) | 2.27853494 |
| 161 | adherens junction assembly (GO:0034333) | 2.27823898 |
| 162 | membrane protein ectodomain proteolysis (GO:0006509) | 2.26601150 |
| 163 | establishment of skin barrier (GO:0061436) | 2.26266798 |
| 164 | embryonic skeletal joint morphogenesis (GO:0060272) | 2.24891911 |
| 165 | establishment of spindle localization (GO:0051293) | 2.24815070 |
| 166 | paraxial mesoderm development (GO:0048339) | 2.24295236 |
| 167 | Golgi to endosome transport (GO:0006895) | 2.20715350 |
| 168 | genitalia morphogenesis (GO:0035112) | 2.20272036 |
| 169 | negative regulation of catenin import into nucleus (GO:0035414) | 2.19359911 |
| 170 | epithelial cell-cell adhesion (GO:0090136) | 2.19224504 |
| 171 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.18979610 |
| 172 | striated muscle atrophy (GO:0014891) | 2.18709416 |
| 173 | collagen fibril organization (GO:0030199) | 2.18498514 |
| 174 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.17275386 |
| 175 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 2.17107876 |
| 176 | negative regulation of cell size (GO:0045792) | 2.16565690 |
| 177 | receptor recycling (GO:0001881) | 2.16339664 |
| 178 | focal adhesion assembly (GO:0048041) | 2.14881274 |
| 179 | cell-substrate adherens junction assembly (GO:0007045) | 2.14881274 |
| 180 | establishment of spindle orientation (GO:0051294) | 2.14318408 |
| 181 | protein localization to endosome (GO:0036010) | 2.12418262 |
| 182 | glomerular visceral epithelial cell development (GO:0072015) | 2.12403664 |
| 183 | gap junction assembly (GO:0016264) | 2.11819353 |
| 184 | mitotic chromosome condensation (GO:0007076) | 2.11224394 |
| 185 | eye morphogenesis (GO:0048592) | 2.10710580 |
| 186 | mitotic cytokinesis (GO:0000281) | 2.10446170 |
| 187 | anterior/posterior axis specification, embryo (GO:0008595) | 2.10341316 |
| 188 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.10133727 |
| 189 | renal filtration (GO:0097205) | 2.10025507 |
| 190 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.09936636 |
| 191 | centrosome duplication (GO:0051298) | 2.07828683 |
| 192 | histone lysine demethylation (GO:0070076) | 2.06224316 |
| 193 | pericardium development (GO:0060039) | 2.05942016 |
| 194 | sperm capacitation (GO:0048240) | 2.05656577 |
| 195 | hippo signaling (GO:0035329) | 2.04003512 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.94093156 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.42725362 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.46039561 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.29632567 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.85876392 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.93030388 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.88359582 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.49094483 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.04801831 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.58552456 |
| 11 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.31956349 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.16864526 |
| 13 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.16318667 |
| 14 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.03381958 |
| 15 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.00511936 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.96692754 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93154267 |
| 18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.91616338 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.91419125 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.85240815 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.83424331 |
| 22 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.79379115 |
| 23 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.77894583 |
| 24 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.77047123 |
| 25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.76490522 |
| 26 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.76396780 |
| 27 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.71611058 |
| 28 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.70279859 |
| 29 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.66916261 |
| 30 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.65829683 |
| 31 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.62905288 |
| 32 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.57991664 |
| 33 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.54174739 |
| 34 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.53438341 |
| 35 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.52259106 |
| 36 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.51095161 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.49244443 |
| 38 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.48952583 |
| 39 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.48304597 |
| 40 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.47684948 |
| 41 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.45926552 |
| 42 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.45926552 |
| 43 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.45553252 |
| 44 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.44073496 |
| 45 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.41022099 |
| 46 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.40978674 |
| 47 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.38376191 |
| 48 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.38376191 |
| 49 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.38211884 |
| 50 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.37781362 |
| 51 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 1.37703471 |
| 52 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.35039835 |
| 53 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.33250575 |
| 54 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.33010783 |
| 55 | KDM2B_26808549_Chip-Seq_K562_Human | 1.31886739 |
| 56 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.31813845 |
| 57 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.31512725 |
| 58 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31357890 |
| 59 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.28128481 |
| 60 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.27350075 |
| 61 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.25992411 |
| 62 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.25132276 |
| 63 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.23319136 |
| 64 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.22579329 |
| 65 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.22397932 |
| 66 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.21489021 |
| 67 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.21470224 |
| 68 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.21455662 |
| 69 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.20618718 |
| 70 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.17166287 |
| 71 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.16611933 |
| 72 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.16186987 |
| 73 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.16012856 |
| 74 | CJUN_26792858_Chip-Seq_BT549_Human | 1.15736154 |
| 75 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.12804269 |
| 76 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.11867396 |
| 77 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.11291114 |
| 78 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.09874475 |
| 79 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.08271069 |
| 80 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.07273662 |
| 81 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06975611 |
| 82 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06225729 |
| 83 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.06188750 |
| 84 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05393683 |
| 85 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05222001 |
| 86 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.04866946 |
| 87 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.04380611 |
| 88 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04173684 |
| 89 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.04084591 |
| 90 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.99713852 |
| 91 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99525929 |
| 92 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.97930711 |
| 93 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.96447977 |
| 94 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94914726 |
| 95 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94030834 |
| 96 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.92115814 |
| 97 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.91692605 |
| 98 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91214684 |
| 99 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.90532829 |
| 100 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.90532829 |
| 101 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89367737 |
| 102 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85250727 |
| 103 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.84569149 |
| 104 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.84302702 |
| 105 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.83675773 |
| 106 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.83416556 |
| 107 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.83312589 |
| 108 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.83174595 |
| 109 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.78531964 |
| 110 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.78465230 |
| 111 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77866328 |
| 112 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.77186238 |
| 113 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.75603832 |
| 114 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.73825754 |
| 115 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72459259 |
| 116 | CBP_21632823_ChIP-Seq_H3396_Human | 0.71774086 |
| 117 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.71513310 |
| 118 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.70871733 |
| 119 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.69043198 |
| 120 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.69008471 |
| 121 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.67899579 |
| 122 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.67649839 |
| 123 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.66898798 |
| 124 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.64835984 |
| 125 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.64744537 |
| 126 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.64398192 |
| 127 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.64393492 |
| 128 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.64015080 |
| 129 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.63854103 |
| 130 | RXR_22108803_ChIP-Seq_LS180_Human | 0.63828005 |
| 131 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.63309772 |
| 132 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.61032047 |
| 133 | TP53_16413492_ChIP-PET_HCT116_Human | 0.60926152 |
| 134 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.59799986 |
| 135 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.58886930 |
| 136 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.57793615 |
| 137 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.57536865 |
| 138 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.57486450 |
| 139 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.56919672 |
| 140 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.56124226 |
| 141 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.55753214 |
| 142 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.55699592 |
| 143 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.55113923 |
| 144 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.55066383 |
| 145 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.54943857 |
| 146 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.53687422 |
| 147 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.53145155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.90508764 |
| 2 | MP0005360_urolithiasis | 6.83687591 |
| 3 | MP0005171_absent_coat_pigmentation | 5.80759355 |
| 4 | MP0005365_abnormal_bile_salt | 5.30989527 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 5.25131883 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.06386730 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.82993297 |
| 8 | MP0003252_abnormal_bile_duct | 3.61671265 |
| 9 | MP0005409_darkened_coat_color | 3.43368910 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 3.07898560 |
| 11 | MP0000015_abnormal_ear_pigmentation | 3.05800949 |
| 12 | MP0009840_abnormal_foam_cell | 2.96117270 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.95856853 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.82954683 |
| 15 | MP0008438_abnormal_cutaneous_collagen | 2.75303186 |
| 16 | MP0000569_abnormal_digit_pigmentation | 2.75208466 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 2.50481411 |
| 18 | MP0003195_calcinosis | 2.46475338 |
| 19 | MP0005332_abnormal_amino_acid | 2.42089314 |
| 20 | MP0005083_abnormal_biliary_tract | 2.41725788 |
| 21 | MP0000372_irregular_coat_pigmentation | 2.32417617 |
| 22 | MP0002877_abnormal_melanocyte_morpholog | 2.25566242 |
| 23 | MP0010352_gastrointestinal_tract_polyps | 2.21451090 |
| 24 | MP0000371_diluted_coat_color | 2.20401587 |
| 25 | MP0005174_abnormal_tail_pigmentation | 2.01005070 |
| 26 | MP0003136_yellow_coat_color | 1.93257686 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 1.88763703 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 1.82639617 |
| 29 | MP0004381_abnormal_hair_follicle | 1.77447713 |
| 30 | MP0003868_abnormal_feces_composition | 1.76766154 |
| 31 | MP0009384_cardiac_valve_regurgitation | 1.76606284 |
| 32 | MP0000609_abnormal_liver_physiology | 1.74210145 |
| 33 | MP0005275_abnormal_skin_tensile | 1.73196492 |
| 34 | MP0002095_abnormal_skin_pigmentation | 1.71735686 |
| 35 | MP0003011_delayed_dark_adaptation | 1.70924327 |
| 36 | MP0005076_abnormal_cell_differentiation | 1.62885843 |
| 37 | MP0002075_abnormal_coat/hair_pigmentati | 1.60779953 |
| 38 | MP0003566_abnormal_cell_adhesion | 1.58114228 |
| 39 | MP0004858_abnormal_nervous_system | 1.57223826 |
| 40 | MP0000537_abnormal_urethra_morphology | 1.52478180 |
| 41 | MP0004264_abnormal_extraembryonic_tissu | 1.52334234 |
| 42 | MP0002089_abnormal_postnatal_growth/wei | 1.49673568 |
| 43 | MP0005503_abnormal_tendon_morphology | 1.49501618 |
| 44 | MP0005319_abnormal_enzyme/_coenzyme | 1.47088022 |
| 45 | MP0000534_abnormal_ureter_morphology | 1.45916002 |
| 46 | MP0003191_abnormal_cellular_cholesterol | 1.45908553 |
| 47 | MP0003091_abnormal_cell_migration | 1.44136316 |
| 48 | MP0005451_abnormal_body_composition | 1.43289297 |
| 49 | MP0010678_abnormal_skin_adnexa | 1.39798040 |
| 50 | MP0001186_pigmentation_phenotype | 1.36643671 |
| 51 | MP0005670_abnormal_white_adipose | 1.36436578 |
| 52 | MP0001348_abnormal_lacrimal_gland | 1.33879601 |
| 53 | MP0002837_dystrophic_cardiac_calcinosis | 1.32784720 |
| 54 | MP0004233_abnormal_muscle_weight | 1.26532012 |
| 55 | MP0003950_abnormal_plasma_membrane | 1.22336798 |
| 56 | MP0000003_abnormal_adipose_tissue | 1.20643017 |
| 57 | MP0001849_ear_inflammation | 1.19091129 |
| 58 | MP0003453_abnormal_keratinocyte_physiol | 1.18117490 |
| 59 | MP0000733_abnormal_muscle_development | 1.17946104 |
| 60 | MP0005075_abnormal_melanosome_morpholog | 1.16938724 |
| 61 | MP0009697_abnormal_copulation | 1.13666835 |
| 62 | MP0010368_abnormal_lymphatic_system | 1.12624551 |
| 63 | MP0001764_abnormal_homeostasis | 1.12588192 |
| 64 | MP0009643_abnormal_urine_homeostasis | 1.12447111 |
| 65 | MP0002060_abnormal_skin_morphology | 1.11620133 |
| 66 | MP0000383_abnormal_hair_follicle | 1.10313533 |
| 67 | MP0008057_abnormal_DNA_replication | 1.07541380 |
| 68 | MP0005666_abnormal_adipose_tissue | 1.05948306 |
| 69 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.05761133 |
| 70 | MP0002138_abnormal_hepatobiliary_system | 1.04410226 |
| 71 | MP0003279_aneurysm | 1.02328487 |
| 72 | MP0001661_extended_life_span | 1.01079938 |
| 73 | MP0002254_reproductive_system_inflammat | 1.00533763 |
| 74 | MP0000467_abnormal_esophagus_morphology | 1.00092885 |
| 75 | MP0005623_abnormal_meninges_morphology | 0.99122633 |
| 76 | MP0004185_abnormal_adipocyte_glucose | 0.95934622 |
| 77 | MP0005220_abnormal_exocrine_pancreas | 0.95717957 |
| 78 | MP0000377_abnormal_hair_follicle | 0.95418414 |
| 79 | MP0002938_white_spotting | 0.95300791 |
| 80 | MP0004130_abnormal_muscle_cell | 0.94105275 |
| 81 | MP0005408_hypopigmentation | 0.93810520 |
| 82 | MP0002098_abnormal_vibrissa_morphology | 0.93165062 |
| 83 | MP0000462_abnormal_digestive_system | 0.92492484 |
| 84 | MP0001324_abnormal_eye_pigmentation | 0.90769724 |
| 85 | MP0002295_abnormal_pulmonary_circulatio | 0.90288283 |
| 86 | MP0002009_preneoplasia | 0.90025897 |
| 87 | MP0005197_abnormal_uvea_morphology | 0.90021791 |
| 88 | MP0005647_abnormal_sex_gland | 0.86702501 |
| 89 | MP0002168_other_aberrant_phenotype | 0.85309463 |
| 90 | MP0000604_amyloidosis | 0.84980813 |
| 91 | MP0009053_abnormal_anal_canal | 0.84929460 |
| 92 | MP0000678_abnormal_parathyroid_gland | 0.84454396 |
| 93 | MP0002896_abnormal_bone_mineralization | 0.84250786 |
| 94 | MP0000579_abnormal_nail_morphology | 0.83917431 |
| 95 | MP0000598_abnormal_liver_morphology | 0.83807474 |
| 96 | MP0000432_abnormal_head_morphology | 0.83466463 |
| 97 | MP0003111_abnormal_nucleus_morphology | 0.83382866 |
| 98 | MP0003115_abnormal_respiratory_system | 0.83205816 |
| 99 | MP0002249_abnormal_larynx_morphology | 0.82214811 |
| 100 | MP0003937_abnormal_limbs/digits/tail_de | 0.80612424 |
| 101 | MP0005501_abnormal_skin_physiology | 0.79783993 |
| 102 | MP0002177_abnormal_outer_ear | 0.79683986 |
| 103 | MP0003941_abnormal_skin_development | 0.77815912 |
| 104 | MP0001216_abnormal_epidermal_layer | 0.76204770 |
| 105 | MP0003329_amyloid_beta_deposits | 0.75006598 |
| 106 | MP0005257_abnormal_intraocular_pressure | 0.74918030 |
| 107 | MP0005023_abnormal_wound_healing | 0.73973961 |
| 108 | MP0002971_abnormal_brown_adipose | 0.73891860 |
| 109 | MP0002108_abnormal_muscle_morphology | 0.72415267 |
| 110 | MP0002269_muscular_atrophy | 0.71641453 |
| 111 | MP0005395_other_phenotype | 0.71515832 |
| 112 | MP0004272_abnormal_basement_membrane | 0.70834734 |
| 113 | MP0001756_abnormal_urination | 0.70439336 |
| 114 | MP0001542_abnormal_bone_strength | 0.70365903 |
| 115 | MP0003656_abnormal_erythrocyte_physiolo | 0.68960224 |
| 116 | MP0002796_impaired_skin_barrier | 0.68953385 |
| 117 | MP0000627_abnormal_mammary_gland | 0.68721513 |
| 118 | MP0004134_abnormal_chest_morphology | 0.68666939 |
| 119 | MP0002078_abnormal_glucose_homeostasis | 0.68394019 |
| 120 | MP0001243_abnormal_dermal_layer | 0.67062500 |
| 121 | MP0005375_adipose_tissue_phenotype | 0.66866389 |
| 122 | MP0002086_abnormal_extraembryonic_tissu | 0.66661104 |
| 123 | MP0003077_abnormal_cell_cycle | 0.66055542 |
| 124 | MP0005621_abnormal_cell_physiology | 0.65915035 |
| 125 | MP0003045_fibrosis | 0.65565096 |
| 126 | MP0009763_increased_sensitivity_to | 0.65320128 |
| 127 | MP0000367_abnormal_coat/_hair | 0.64513931 |
| 128 | MP0005187_abnormal_penis_morphology | 0.64455503 |
| 129 | MP0005330_cardiomyopathy | 0.64413242 |
| 130 | MP0002084_abnormal_developmental_patter | 0.64376608 |
| 131 | MP0001915_intracranial_hemorrhage | 0.63741332 |
| 132 | MP0000013_abnormal_adipose_tissue | 0.63592463 |
| 133 | MP0000428_abnormal_craniofacial_morphol | 0.63371260 |
| 134 | MP0005410_abnormal_fertilization | 0.63107400 |
| 135 | MP0005334_abnormal_fat_pad | 0.63087832 |
| 136 | MP0003690_abnormal_glial_cell | 0.62630487 |
| 137 | MP0010771_integument_phenotype | 0.62557868 |
| 138 | MP0001958_emphysema | 0.62038046 |
| 139 | MP0000538_abnormal_urinary_bladder | 0.61800156 |
| 140 | MP0002697_abnormal_eye_size | 0.60653914 |
| 141 | MP0000762_abnormal_tongue_morphology | 0.60622068 |
| 142 | MP0010307_abnormal_tumor_latency | 0.60516181 |
| 143 | MP0005058_abnormal_lysosome_morphology | 0.60459061 |
| 144 | MP0002114_abnormal_axial_skeleton | 0.60448306 |
| 145 | MP0005380_embryogenesis_phenotype | 0.59760945 |
| 146 | MP0001672_abnormal_embryogenesis/_devel | 0.59760945 |
| 147 | MP0003984_embryonic_growth_retardation | 0.59659800 |
| 148 | MP0003385_abnormal_body_wall | 0.59446904 |
| 149 | MP0003935_abnormal_craniofacial_develop | 0.58798584 |
| 150 | MP0009780_abnormal_chondrocyte_physiolo | 0.58430715 |
| 151 | MP0005636_abnormal_mineral_homeostasis | 0.58374910 |
| 152 | MP0009642_abnormal_blood_homeostasis | 0.58249936 |
| 153 | MP0005551_abnormal_eye_electrophysiolog | 0.57064802 |
| 154 | MP0003300_gastrointestinal_ulcer | 0.56794272 |
| 155 | MP0005376_homeostasis/metabolism_phenot | 0.55362147 |
| 156 | MP0005084_abnormal_gallbladder_morpholo | 0.54850684 |
| 157 | MP0010030_abnormal_orbit_morphology | 0.53046882 |
| 158 | MP0005448_abnormal_energy_balance | 0.53014632 |
| 159 | MP0006138_congestive_heart_failure | 0.52228506 |
| 160 | MP0000427_abnormal_hair_cycle | 0.51831457 |
| 161 | MP0000566_synostosis | 0.51539503 |
| 162 | MP0003186_abnormal_redox_activity | 0.50625951 |
| 163 | MP0005248_abnormal_Harderian_gland | 0.47633625 |
| 164 | MP0009672_abnormal_birth_weight | 0.46816382 |
| 165 | MP0002876_abnormal_thyroid_physiology | 0.46759711 |
| 166 | MP0000747_muscle_weakness | 0.46421675 |
| 167 | MP0009764_decreased_sensitivity_to | 0.45919671 |
| 168 | MP0002090_abnormal_vision | 0.45869623 |
| 169 | MP0005508_abnormal_skeleton_morphology | 0.45316761 |
| 170 | MP0009115_abnormal_fat_cell | 0.44542808 |
| 171 | MP0004087_abnormal_muscle_fiber | 0.43761602 |
| 172 | MP0000163_abnormal_cartilage_morphology | 0.43062692 |
| 173 | MP0000230_abnormal_systemic_arterial | 0.43027643 |
| 174 | MP0001299_abnormal_eye_distance/ | 0.43026062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.26490445 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.16835642 |
| 3 | Xanthomatosis (HP:0000991) | 5.81998904 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.60098775 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.19523955 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.07453698 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.88407446 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.45819895 |
| 9 | Hypolipoproteinemia (HP:0010981) | 4.26824309 |
| 10 | Hypoalphalipoproteinemia (HP:0003233) | 4.06804411 |
| 11 | Complement deficiency (HP:0004431) | 4.04556031 |
| 12 | Epidermoid cyst (HP:0200040) | 3.95096400 |
| 13 | Hyperglycinuria (HP:0003108) | 3.93417734 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.85947125 |
| 15 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.85413992 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 3.85413992 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.83386935 |
| 18 | Fat malabsorption (HP:0002630) | 3.81821140 |
| 19 | Hyperglycinemia (HP:0002154) | 3.81246213 |
| 20 | Hyperammonemia (HP:0001987) | 3.77927210 |
| 21 | Ketosis (HP:0001946) | 3.75209936 |
| 22 | Blue irides (HP:0000635) | 3.72401588 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.72185747 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 3.69414148 |
| 25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.68931175 |
| 26 | Hypoglycemic coma (HP:0001325) | 3.68856971 |
| 27 | White forelock (HP:0002211) | 3.57461819 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 3.53210044 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.37171279 |
| 30 | Hypopigmentation of the fundus (HP:0007894) | 3.36465537 |
| 31 | Premature rupture of membranes (HP:0001788) | 3.27652971 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.24718052 |
| 33 | Protrusio acetabuli (HP:0003179) | 3.24632134 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.16673404 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.16192610 |
| 36 | Patchy hypopigmentation of hair (HP:0011365) | 3.04402800 |
| 37 | Myocardial infarction (HP:0001658) | 2.98529946 |
| 38 | Ketoacidosis (HP:0001993) | 2.95335317 |
| 39 | Hypercholesterolemia (HP:0003124) | 2.93811814 |
| 40 | Skin nodule (HP:0200036) | 2.90722152 |
| 41 | Ulnar bowing (HP:0003031) | 2.87594860 |
| 42 | Joint hemorrhage (HP:0005261) | 2.86624682 |
| 43 | Hypoplasia of the iris (HP:0007676) | 2.84587993 |
| 44 | Abnormality of complement system (HP:0005339) | 2.81697659 |
| 45 | Cerebral aneurysm (HP:0004944) | 2.76546908 |
| 46 | Steatorrhea (HP:0002570) | 2.72271535 |
| 47 | Shallow orbits (HP:0000586) | 2.69229894 |
| 48 | Mitral stenosis (HP:0001718) | 2.62158526 |
| 49 | Flat acetabular roof (HP:0003180) | 2.57829193 |
| 50 | Cardiovascular calcification (HP:0011915) | 2.54421480 |
| 51 | Gout (HP:0001997) | 2.48228854 |
| 52 | Peritonitis (HP:0002586) | 2.47631085 |
| 53 | Abnormality of serum amino acid levels (HP:0003112) | 2.46887379 |
| 54 | Hyperglycemia (HP:0003074) | 2.44386710 |
| 55 | Abnormality of purine metabolism (HP:0004352) | 2.43886494 |
| 56 | Vascular calcification (HP:0004934) | 2.39082153 |
| 57 | Hyperbilirubinemia (HP:0002904) | 2.38806000 |
| 58 | Pigmentary retinal degeneration (HP:0001146) | 2.37517830 |
| 59 | Abnormality of nucleobase metabolism (HP:0010932) | 2.36981223 |
| 60 | Hypoglycemic seizures (HP:0002173) | 2.34798612 |
| 61 | Hepatocellular carcinoma (HP:0001402) | 2.34061482 |
| 62 | Ocular albinism (HP:0001107) | 2.33578073 |
| 63 | Malnutrition (HP:0004395) | 2.33086570 |
| 64 | Acanthocytosis (HP:0001927) | 2.31873006 |
| 65 | Turricephaly (HP:0000262) | 2.31150035 |
| 66 | Dicarboxylic aciduria (HP:0003215) | 2.26778403 |
| 67 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.26778403 |
| 68 | Thin bony cortex (HP:0002753) | 2.26713000 |
| 69 | Dysmetric saccades (HP:0000641) | 2.26107857 |
| 70 | Hyperacusis (HP:0010780) | 2.25679942 |
| 71 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.25312566 |
| 72 | Right ventricular cardiomyopathy (HP:0011663) | 2.23619593 |
| 73 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.23170682 |
| 74 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.22090585 |
| 75 | Spontaneous abortion (HP:0005268) | 2.21131874 |
| 76 | Atrophic scars (HP:0001075) | 2.20667334 |
| 77 | Chorioretinal atrophy (HP:0000533) | 2.18365197 |
| 78 | Neonatal short-limb short stature (HP:0008921) | 2.18214207 |
| 79 | Abnormality of proline metabolism (HP:0010907) | 2.17149002 |
| 80 | Hydroxyprolinuria (HP:0003080) | 2.17149002 |
| 81 | Metabolic acidosis (HP:0001942) | 2.17030953 |
| 82 | Abnormality of the nasal septum (HP:0000419) | 2.14706870 |
| 83 | Broad face (HP:0000283) | 2.13782727 |
| 84 | Distal upper limb amyotrophy (HP:0007149) | 2.13262694 |
| 85 | Upper limb amyotrophy (HP:0009129) | 2.13262694 |
| 86 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.13030567 |
| 87 | Renovascular hypertension (HP:0100817) | 2.11924003 |
| 88 | Hypophosphatemic rickets (HP:0004912) | 2.11092251 |
| 89 | Abnormal gallbladder morphology (HP:0012437) | 2.10793384 |
| 90 | Ileus (HP:0002595) | 2.09168683 |
| 91 | Sensorimotor neuropathy (HP:0007141) | 2.08159581 |
| 92 | Persistence of primary teeth (HP:0006335) | 2.08044288 |
| 93 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.05492517 |
| 94 | Protuberant abdomen (HP:0001538) | 2.05246598 |
| 95 | Delayed CNS myelination (HP:0002188) | 2.03345782 |
| 96 | Hand muscle atrophy (HP:0009130) | 2.01765821 |
| 97 | Abnormal auditory evoked potentials (HP:0006958) | 2.01752481 |
| 98 | Rickets (HP:0002748) | 2.01226571 |
| 99 | Cholelithiasis (HP:0001081) | 2.00756999 |
| 100 | Hypochromic microcytic anemia (HP:0004840) | 2.00383168 |
| 101 | Abnormal cartilage morphology (HP:0002763) | 1.99074783 |
| 102 | Hyperkalemia (HP:0002153) | 1.98879973 |
| 103 | Cervical subluxation (HP:0003308) | 1.98668108 |
| 104 | Advanced eruption of teeth (HP:0006288) | 1.98441450 |
| 105 | Abnormal delivery (HP:0001787) | 1.97582692 |
| 106 | Ectopia lentis (HP:0001083) | 1.94925764 |
| 107 | Natal tooth (HP:0000695) | 1.94637112 |
| 108 | Heterotopia (HP:0002282) | 1.93732432 |
| 109 | Lethargy (HP:0001254) | 1.92974917 |
| 110 | Infantile muscular hypotonia (HP:0008947) | 1.91034120 |
| 111 | Tibial bowing (HP:0002982) | 1.90688214 |
| 112 | Lip pit (HP:0100267) | 1.89454837 |
| 113 | Hyporeflexia of lower limbs (HP:0002600) | 1.89286087 |
| 114 | Enlarged kidneys (HP:0000105) | 1.89155727 |
| 115 | Broad metatarsal (HP:0001783) | 1.88988093 |
| 116 | Bell-shaped thorax (HP:0001591) | 1.88225260 |
| 117 | Congenital sensorineural hearing impairment (HP:0008527) | 1.87447023 |
| 118 | Amyloidosis (HP:0011034) | 1.87095135 |
| 119 | Bladder diverticulum (HP:0000015) | 1.86671488 |
| 120 | Relative macrocephaly (HP:0004482) | 1.85902290 |
| 121 | Long toe (HP:0010511) | 1.85354815 |
| 122 | Aortic aneurysm (HP:0004942) | 1.84434449 |
| 123 | Aortic dissection (HP:0002647) | 1.83954302 |
| 124 | Increased connective tissue (HP:0009025) | 1.81420166 |
| 125 | Systemic lupus erythematosus (HP:0002725) | 1.80622165 |
| 126 | Proximal tubulopathy (HP:0000114) | 1.80363821 |
| 127 | Wormian bones (HP:0002645) | 1.79570963 |
| 128 | Cupped ribs (HP:0000887) | 1.79109051 |
| 129 | Fragile skin (HP:0001030) | 1.78790613 |
| 130 | Elbow flexion contracture (HP:0002987) | 1.77790398 |
| 131 | Short nail (HP:0001799) | 1.77413939 |
| 132 | Abnormality of the acetabulum (HP:0003170) | 1.76303073 |
| 133 | Irritability (HP:0000737) | 1.76061889 |
| 134 | Abnormality of the gallbladder (HP:0005264) | 1.75951997 |
| 135 | Esophageal varix (HP:0002040) | 1.75534921 |
| 136 | Termporal pattern (HP:0011008) | 1.75398982 |
| 137 | Insidious onset (HP:0003587) | 1.75398982 |
| 138 | Late onset (HP:0003584) | 1.73960518 |
| 139 | Osteolytic defects of the hand bones (HP:0009699) | 1.73695020 |
| 140 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.73695020 |
| 141 | Increased purine levels (HP:0004368) | 1.73157610 |
| 142 | Hyperuricemia (HP:0002149) | 1.73157610 |
| 143 | Biconcave vertebral bodies (HP:0004586) | 1.72209357 |
| 144 | Underdeveloped nasal alae (HP:0000430) | 1.72077141 |
| 145 | Renal cortical cysts (HP:0000803) | 1.70162978 |
| 146 | Macroorchidism (HP:0000053) | 1.70140242 |
| 147 | Cholecystitis (HP:0001082) | 1.69465023 |
| 148 | Abnormal gallbladder physiology (HP:0012438) | 1.69465023 |
| 149 | Symptomatic seizures (HP:0011145) | 1.69295711 |
| 150 | Synophrys (HP:0000664) | 1.68963404 |
| 151 | Glycosuria (HP:0003076) | 1.68632302 |
| 152 | Abnormality of urine glucose concentration (HP:0011016) | 1.68632302 |
| 153 | Vertebral arch anomaly (HP:0008438) | 1.68421777 |
| 154 | Genetic anticipation (HP:0003743) | 1.67608404 |
| 155 | Iris hypopigmentation (HP:0007730) | 1.64411407 |
| 156 | Long eyelashes (HP:0000527) | 1.63451165 |
| 157 | Abnormality of carpal bone ossification (HP:0006257) | 1.63349035 |
| 158 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.62582959 |
| 159 | Dislocated radial head (HP:0003083) | 1.62369290 |
| 160 | Overgrowth (HP:0001548) | 1.62107479 |
| 161 | Freckling (HP:0001480) | 1.61562018 |
| 162 | Bowing of the arm (HP:0006488) | 1.61532229 |
| 163 | Bowed forearm bones (HP:0003956) | 1.61532229 |
| 164 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.61202657 |
| 165 | Disproportionate tall stature (HP:0001519) | 1.60889504 |
| 166 | Generalized hypopigmentation of hair (HP:0011358) | 1.60815481 |
| 167 | Asymmetry of the thorax (HP:0001555) | 1.60528354 |
| 168 | Hamartoma of the eye (HP:0010568) | 1.60282379 |
| 169 | Heterochromia iridis (HP:0001100) | 1.58494896 |
| 170 | Laryngomalacia (HP:0001601) | 1.57464887 |
| 171 | Germ cell neoplasia (HP:0100728) | 1.56555573 |
| 172 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.55630484 |
| 173 | Abnormal ossification of hand bones (HP:0005921) | 1.54171298 |
| 174 | Arterial tortuosity (HP:0005116) | 1.54075411 |
| 175 | Mitral valve prolapse (HP:0001634) | 1.53736912 |
| 176 | Aneurysm (HP:0002617) | 1.53633753 |
| 177 | Decreased lacrimation (HP:0000633) | 1.53534160 |
| 178 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.52934107 |
| 179 | Aplasia involving bones of the extremities (HP:0009825) | 1.52612597 |
| 180 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.52612597 |
| 181 | Aplasia of the phalanges of the hand (HP:0009802) | 1.52612597 |
| 182 | Abnormality of dentin (HP:0010299) | 1.51671884 |
| 183 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.49034869 |
| 184 | Joint laxity (HP:0001388) | 1.48674356 |
| 185 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.48485376 |
| 186 | Coarse hair (HP:0002208) | 1.45215077 |
| 187 | Spinal cord compression (HP:0002176) | 1.45161225 |
| 188 | Vascular tortuosity (HP:0004948) | 1.44971380 |
| 189 | Sandal gap (HP:0001852) | 1.44305174 |
| 190 | Sparse lateral eyebrow (HP:0005338) | 1.44036769 |
| 191 | Blue sclerae (HP:0000592) | 1.42800002 |
| 192 | Limited elbow extension (HP:0001377) | 1.41558966 |
| 193 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 1.41193513 |
| 194 | Narrow palate (HP:0000189) | 1.41143547 |
| 195 | Alacrima (HP:0000522) | 1.40301250 |
| 196 | Abdominal distention (HP:0003270) | 1.40224403 |
| 197 | Abnormality of the fingertips (HP:0001211) | 1.40160906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK1 | 4.73218614 |
| 2 | CDK12 | 4.38994225 |
| 3 | BCKDK | 3.97733515 |
| 4 | LATS1 | 3.75789152 |
| 5 | ERN1 | 3.47051606 |
| 6 | EEF2K | 2.87853530 |
| 7 | FGFR4 | 2.71155197 |
| 8 | FRK | 2.35821066 |
| 9 | INSRR | 2.31643013 |
| 10 | DDR2 | 2.29489148 |
| 11 | BRD4 | 2.18516162 |
| 12 | ERBB4 | 2.13082394 |
| 13 | EPHB1 | 2.06277697 |
| 14 | TRIB3 | 2.01645395 |
| 15 | TAOK3 | 1.97698378 |
| 16 | TTN | 1.95246173 |
| 17 | STK38L | 1.93063781 |
| 18 | FGFR2 | 1.89707040 |
| 19 | LMTK2 | 1.87785926 |
| 20 | SMG1 | 1.69520221 |
| 21 | MST1R | 1.67741031 |
| 22 | PIK3CA | 1.63323073 |
| 23 | EPHA3 | 1.62384561 |
| 24 | PNCK | 1.58703994 |
| 25 | PDGFRA | 1.53279844 |
| 26 | PIK3CG | 1.50626319 |
| 27 | MET | 1.50600929 |
| 28 | PTK6 | 1.48668084 |
| 29 | NEK9 | 1.45680037 |
| 30 | PRKD3 | 1.40063622 |
| 31 | PBK | 1.39253556 |
| 32 | PAK3 | 1.36084119 |
| 33 | CAMK1D | 1.31596826 |
| 34 | LATS2 | 1.25172877 |
| 35 | PRKAA2 | 1.20149346 |
| 36 | MAP3K3 | 1.18860676 |
| 37 | PTK2 | 1.15689862 |
| 38 | STK3 | 1.14644743 |
| 39 | AKT3 | 1.12170152 |
| 40 | MAPK11 | 1.09671335 |
| 41 | CDK7 | 1.06046778 |
| 42 | FGFR1 | 1.04167369 |
| 43 | FER | 1.03341507 |
| 44 | STK39 | 1.00990311 |
| 45 | JAK1 | 0.99424540 |
| 46 | CAMK1G | 0.98825577 |
| 47 | ERBB2 | 0.96502950 |
| 48 | MTOR | 0.96335648 |
| 49 | PDPK1 | 0.95675962 |
| 50 | WNK4 | 0.95354676 |
| 51 | PKN2 | 0.94053142 |
| 52 | PDK3 | 0.92227214 |
| 53 | PDK4 | 0.92227214 |
| 54 | PRKD2 | 0.92185593 |
| 55 | NUAK1 | 0.91858784 |
| 56 | CDC42BPA | 0.87915704 |
| 57 | BMX | 0.87340467 |
| 58 | PRKAA1 | 0.86742002 |
| 59 | MAP3K7 | 0.86245423 |
| 60 | TBK1 | 0.85696990 |
| 61 | PAK2 | 0.84909324 |
| 62 | PRKD1 | 0.82425202 |
| 63 | IRAK3 | 0.82288323 |
| 64 | RPS6KA2 | 0.80622027 |
| 65 | MAPKAPK3 | 0.80176504 |
| 66 | PKN1 | 0.78948881 |
| 67 | ABL2 | 0.77656818 |
| 68 | ICK | 0.77600168 |
| 69 | MAP2K4 | 0.77125474 |
| 70 | WEE1 | 0.75369790 |
| 71 | EPHB2 | 0.75138639 |
| 72 | PDGFRB | 0.74411218 |
| 73 | MAP2K1 | 0.73331896 |
| 74 | PAK4 | 0.69856290 |
| 75 | PDK2 | 0.69459240 |
| 76 | MAPKAPK5 | 0.68696878 |
| 77 | MAP2K2 | 0.68407047 |
| 78 | MAPK12 | 0.66980274 |
| 79 | NEK6 | 0.66837207 |
| 80 | RIPK1 | 0.65791433 |
| 81 | MAP3K10 | 0.65370379 |
| 82 | TRPM7 | 0.64223179 |
| 83 | CDK9 | 0.63029317 |
| 84 | TYRO3 | 0.62749404 |
| 85 | CDK6 | 0.62740961 |
| 86 | FGFR3 | 0.62692084 |
| 87 | MAP3K2 | 0.60699388 |
| 88 | RPS6KB1 | 0.60007987 |
| 89 | CHEK1 | 0.59232556 |
| 90 | EPHA2 | 0.58418518 |
| 91 | OXSR1 | 0.56127658 |
| 92 | ROCK1 | 0.54866204 |
| 93 | PHKG1 | 0.53597166 |
| 94 | PHKG2 | 0.53597166 |
| 95 | MARK2 | 0.53172121 |
| 96 | OBSCN | 0.53019402 |
| 97 | SGK223 | 0.52807668 |
| 98 | SGK494 | 0.52807668 |
| 99 | SGK3 | 0.52397349 |
| 100 | PRKACG | 0.52211386 |
| 101 | TTK | 0.51567107 |
| 102 | WNK1 | 0.51238949 |
| 103 | CSNK1A1L | 0.50520154 |
| 104 | DMPK | 0.49438949 |
| 105 | NEK1 | 0.49354781 |
| 106 | ACVR1B | 0.49127190 |
| 107 | PRPF4B | 0.48276222 |
| 108 | GSK3A | 0.48117462 |
| 109 | AKT2 | 0.45952166 |
| 110 | CHUK | 0.45491695 |
| 111 | CAMK2G | 0.44344691 |
| 112 | BRSK2 | 0.43592241 |
| 113 | JAK2 | 0.43038177 |
| 114 | IGF1R | 0.42921486 |
| 115 | NTRK1 | 0.42172247 |
| 116 | KSR2 | 0.40846787 |
| 117 | SCYL2 | 0.40044937 |
| 118 | GSK3B | 0.39792925 |
| 119 | RET | 0.39520277 |
| 120 | TAOK2 | 0.38870351 |
| 121 | PRKCZ | 0.38588558 |
| 122 | MAPK7 | 0.38413430 |
| 123 | MELK | 0.38274335 |
| 124 | MYLK | 0.38243860 |
| 125 | CDK1 | 0.37808809 |
| 126 | CAMK2D | 0.37317700 |
| 127 | MAP3K8 | 0.36072269 |
| 128 | PLK4 | 0.35927655 |
| 129 | MAPK10 | 0.35560079 |
| 130 | PRKG2 | 0.35469409 |
| 131 | GRK1 | 0.35189861 |
| 132 | PDK1 | 0.34866097 |
| 133 | MAPK1 | 0.34381717 |
| 134 | DYRK1B | 0.34072819 |
| 135 | SGK2 | 0.33582356 |
| 136 | CHEK2 | 0.32726853 |
| 137 | PAK6 | 0.31519135 |
| 138 | PLK2 | 0.30896539 |
| 139 | STK38 | 0.30702902 |
| 140 | MAPK14 | 0.30457409 |
| 141 | PINK1 | 0.30403326 |
| 142 | CDK2 | 0.30336568 |
| 143 | MAPK8 | 0.30256059 |
| 144 | PRKCH | 0.29757221 |
| 145 | SGK1 | 0.28435208 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.89338436 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.53661815 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.04127686 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.74567633 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.72454035 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.69192527 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.54112939 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.53522516 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.52791385 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.48338762 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.44800961 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.36880526 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.19025378 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.17994097 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.10886798 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.01449091 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.95817112 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.89628588 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.83312410 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.79910584 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.76731038 |
| 22 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.76402659 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.72718826 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.69037410 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.64834859 |
| 26 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.64184555 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.63723815 |
| 28 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.60205894 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.58398400 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.57111310 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.57110527 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.55167907 |
| 33 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.54589279 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.53594277 |
| 35 | * Adherens junction_Homo sapiens_hsa04520 | 1.53240565 |
| 36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.51505613 |
| 37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.50998885 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.46626588 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.46316063 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45056292 |
| 41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.44499106 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.43955526 |
| 43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.40269663 |
| 44 | Prostate cancer_Homo sapiens_hsa05215 | 1.37092476 |
| 45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.34181275 |
| 46 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.30378662 |
| 47 | Thyroid cancer_Homo sapiens_hsa05216 | 1.30092946 |
| 48 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.27219009 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.25069578 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.24419952 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.21944643 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.21029298 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20085685 |
| 54 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.18886672 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.18846492 |
| 56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.18426125 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 1.18026827 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.17636131 |
| 59 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.16220163 |
| 60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15750073 |
| 61 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.15584583 |
| 62 | Glioma_Homo sapiens_hsa05214 | 1.14206238 |
| 63 | Endometrial cancer_Homo sapiens_hsa05213 | 1.14002311 |
| 64 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.13490649 |
| 65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.12324277 |
| 66 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.11790966 |
| 67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.10326013 |
| 68 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.05752597 |
| 69 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.05095749 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 1.04292221 |
| 71 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.03826454 |
| 72 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.03765796 |
| 73 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.00539473 |
| 74 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.00220134 |
| 75 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99389372 |
| 76 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.96589081 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.96026771 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.94740373 |
| 79 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.94654047 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.93606305 |
| 81 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.90132721 |
| 82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88807240 |
| 83 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87932560 |
| 84 | Tight junction_Homo sapiens_hsa04530 | 0.85181002 |
| 85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.83812534 |
| 86 | Melanogenesis_Homo sapiens_hsa04916 | 0.80577437 |
| 87 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.80074886 |
| 88 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.79614176 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77215987 |
| 90 | Melanoma_Homo sapiens_hsa05218 | 0.76190481 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.75918703 |
| 92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.72843862 |
| 93 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.72405126 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71948068 |
| 95 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.70846818 |
| 96 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.70221033 |
| 97 | Other glycan degradation_Homo sapiens_hsa00511 | 0.69358778 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67690948 |
| 99 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66388031 |
| 100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66247322 |
| 101 | Axon guidance_Homo sapiens_hsa04360 | 0.64331506 |
| 102 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.63117510 |
| 103 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62803945 |
| 104 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.62650028 |
| 105 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61301826 |
| 106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61078341 |
| 107 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.59506630 |
| 108 | Cell cycle_Homo sapiens_hsa04110 | 0.59067518 |
| 109 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.58814463 |
| 110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58742790 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58145267 |
| 112 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.57948396 |
| 113 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55581696 |
| 114 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.54719500 |
| 115 | Pathways in cancer_Homo sapiens_hsa05200 | 0.53642997 |
| 116 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.52502214 |
| 117 | Hepatitis C_Homo sapiens_hsa05160 | 0.52430773 |
| 118 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.51659924 |
| 119 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51445118 |
| 120 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.48583355 |
| 121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47509335 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44055054 |
| 123 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43739881 |
| 124 | Insulin resistance_Homo sapiens_hsa04931 | 0.43013305 |
| 125 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42127804 |
| 126 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42050059 |
| 127 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41284423 |
| 128 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40552995 |
| 129 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.40047749 |
| 130 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.38556384 |
| 131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32551360 |
| 132 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29943017 |
| 133 | Mineral absorption_Homo sapiens_hsa04978 | 0.29686098 |
| 134 | Phototransduction_Homo sapiens_hsa04744 | 0.26753004 |
| 135 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.25032899 |
| 136 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.23351086 |
| 137 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.22391191 |
| 138 | Prion diseases_Homo sapiens_hsa05020 | 0.21868128 |
| 139 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.21372931 |
| 140 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.18020439 |
| 141 | Amoebiasis_Homo sapiens_hsa05146 | 0.15967204 |
| 142 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.14070452 |
| 143 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.12828481 |
| 144 | Circadian rhythm_Homo sapiens_hsa04710 | 0.10022761 |
| 145 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.06181132 |
| 146 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.04101655 |
| 147 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.03811995 |
| 148 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.02761056 |
| 149 | Bladder cancer_Homo sapiens_hsa05219 | 0.00989056 |
| 150 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.00085295 |
| 151 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0455947 |
| 152 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0130858 |
| 153 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | -0.0069704 |
| 154 | Focal adhesion_Homo sapiens_hsa04510 | -0.0058281 |

